This continued display of greed and total disregard for the value of the company and its shareholders for transactions that only benefit the chosen few insiders if not illegal, certainly seems close to it, especially in light of the public, official open letter to shareholders of what the company's plans were to be.
I have patience for scientific development. I have patience for interruptions and setbacks encountered in honest endeavors. I have very little patience for those who lie or deceive and that taste is coming from the continued practices revealed in these filings. In light of that fact, I have sent the following:
Dear Mr. Landers,
Our hope was that your arrival would put RGBP in a more professional, business mode of fair practices regarding the transactions of RGBP. Your open-letter to shareholders in January acknowledged the highly discounted shares given out to Koos, friends and family that have made the financial filings a huge red flag to any serious outside and stable investor. This was promised to be ending in Q1 of 2016.
Yet, days before Q1 ended, shares were handed out not only at the rate of .05/share, but even lower to the lowest level of .0125/share for preferred! How is that an improvement?
Now today, we shareholders are informed that not only have the big 3 handed themselves 10,000,000 preferred shares (at a rate of over $1,000,000 a person is price of preferred shares are only equal to common shares, but as further insult to shareholders, $10,000 of debt is offset for .01/preferred share price with 1,000,000 preferred shares. This is crazy. Many of the shareholders that invested in this company from BMSN on have invested far more than $10,000 and we do not have close to 1,000,000 common shares for our money. I don’t think the SEC smiles on companies who may fill out the proper forms, but whose business practices raise many flags.
As these practices continue to the sole benefit of a few insiders and to the devaluation of every shareholder on a preposterous scale, please reflect on the fact that litigation is not out of the question on behalf of shareholders as public company promises are not held and totally disregarded.
I once had great hopes for this company, but the more transactions I see, the less hope I have for this company as a true company. Rather, more and more it appears as an organization with some great science, but hell bent on securing the rewards of a few insiders.
Extremely disappointed in this recent 8-K
